FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/100240 [Registered on: 02/01/2026] Trial Registered Prospectively
Last Modified On: 07/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison Of Analgesic Efficacy Of Nebulized Dexmedetomidine And Lignocaine On Post-Operative Pain in tonsillectomy Under General Anaesthesia.  
Scientific Title of Study   Comparison of analgesic efficacy of nebulized dexmedetomidine and lignocaine on post-operative pain in pediatric tonsillectomy under 
Trial Acronym  CAENDL-PPT 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Surbhi Kataria  
Designation  DNB resident , department of anesthesiology  
Affiliation  BPS GMC khanpur kalan , sonepat  
Address  DEPARTMENT OF ANAESTHESIOLOGY,BPS GMC KHANPUR KALAN SONIPAT
DEPARTMENT OF ANAESTHESIOLOGY , BPS GMC KHANPUR KALAN SONIPAT
Sonipat
HARYANA
131505
India 
Phone  8076532728  
Fax    
Email  Katariasurbhii43@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR KIRTI AHUJA 
Designation  PROFESSOR , MBBS , MD (ANAESTHESIA) 
Affiliation  BPS GMC KHANPUR KALAN SONIPAT 
Address  DEPARTMENT OF ANAESTHESIOLOGY,BPS GMC KHANPUR KALAN SONIPAT
DEPARTMENT OF ANAESTHESIOLOGY,BPS GMC KHANPUR KALAN SONIPAT
Sonipat
HARYANA
131305
India 
Phone  9992111890  
Fax    
Email  kirtiahuja2812@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR PRATEEK 
Designation  ASSISTANT PROFESSOR , MBBS ,MD (ANAESTHESIA)D  
Affiliation  DEPARTMENT OF ANAESTHESIOLOGY,BPS GMC KHANPUR KALAN SONIPAT 
Address  DEPARTMENT OF ANAESTHESIOLOGY,BPS GMC KHANPUR KALAN SONIPAT
DEPARTMENT OF ANAESTHESIOLOGY,BPS GMC KHANPUR KALAN SONIPAT
Sonipat
HARYANA
131305
India 
Phone  8683973839  
Fax    
Email  neopatricks@gmail.com  
 
Source of Monetary or Material Support  
Self/institution 
 
Primary Sponsor  
Name  BPSGMC KHANPUR KALAN SONIPAT 
Address  BPSGMC KHANPUR KALAN SONIPAT 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR SURBHI KATARIA  BPSGMC for Women KHANPUR KALAN SONIPAT  BPSGMC for WOMEN KHANPUR KALAN SONIPAT HARYANA
Sonipat
HARYANA 
8076532728

katariasurbhii43@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
BPSGMC FOR WOMEN KHANPUR KALAN SONIPAT  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Approved/Obtained 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J039||Acute tonsillitis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  DEXMEDETOMIDINE  1. Nebulization with dexmedetomidine 2 µg/kg diluted upto 4 mL with normal saline 30 minutes before induction  
Comparator Agent  LIGNOCAINE  Nebulization with lignocaine 4% solution, 4 mg/kg in 4ml normal saline 30 minutes prior to induction . 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  4.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  1.Pediatric patients aged between 4 to 12 years
2.Scheduled for elective tonsillectomy under general anaesthesia.
2.ASA physical status I or II. 
 
ExclusionCriteria 
Details  1.Patients with any congenital abnormality
2.Patients with upper respiratory tract infection and having known allergy to dexmedetomidine, lignocaine, or any other local anaesthetics.
3.History of any neurological disorders (e.g., cerebral palsy, epilepsy).
4.Severe systemic illnesses (e.g., cardiovascular, hepatic, or renal diseases).
5.Children with a history of previous airway surgery
6.Patients and /or his/her legally acceptable representative not willing to participate in the present study.

SAMPLE SIZE AND SAMPLING:

As per previously conducted study 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Duration of effective postperative analgesia (Time of first rescue analgesic and total analgesic doses in 24 hours)
 
Every 30 minutes  
 
Secondary Outcome  
Outcome  TimePoints 
Time to first oral intake   
Emergence agitation score using PAED scale  followed @ 5,10,15 and 30 min post-extubation 
Sedation score  @ 1 and 24 hours interval 
Haemodynamic parameters  Prenebulisation,postnebulisation,@induction ,every 5 minutes intraoperatively and post operatively @30 min.,1,2,4,6,12,24 hours interval 
Incidence of side effects (bradycardia,hypotension,nausea,vomiting,respiratory depression)   
 
Target Sample Size   Total Sample Size="74"
Sample Size from India="37" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   12/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details
Modification(s)  
will be published as thesis and research article as applicable 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [Katariasurbhii43@gmail.com].

  6. For how long will this data be available start date provided 30-05-2028 and end date provided 12-10-2031?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary
Modification(s)  

This randomised, double-blind, controlled study will be conducted to compare the analgesic efficacy of nebulisation with Dexmedetomidine and Lignocaine on postoperative pain in pediatric patient posted for tonsillectomy under general anaesthesia. The primary objective will be to compare the duration of postoperative analgesia while secondary objective will be to  compare the incidence and severity of emergence delirium, and compare the haemodynamic parameters preoperatively, intraoperatively and postoperatively between the groups , to assess and compare the sedation level using standardized sedation scale , to assess the level of anxiety by child separation score, to assess the incidence of adverse effects such as bradycardia, hypotension, respiratory depression ,nausea ,vomiting .The study will be carried out in Department of Anaesthesia OT complex & ENT ward at Bhagat Phool Singh Government Medical College , Khanpur Kalyan ,Sonepat , over a 18 month period, enrolling a total of 74 children aged 4 to 1years undergoing tonsillectomy under general anaesthesia. Patients who meet the inclusion criteria (ASA physical status I or II) will be randomly allocated into two groups of 37 each. Group D (Dexmedetomidine) will receive nebulization with Dexmedetomidine 2mcg/kg diluted upto 4ml with normal saline 30 minutes before induction. Group L (Lignocaine) will receive nebulization with Lignocaine 4% solution,4mg/kg in 4ml normal saline 30minutes prior to induction. Randomisation will be done using computer-generated random numbers, and drug preparation will be performed by an anaesthesiologist not involved in outcome assessment. After pre-anaesthetic evaluation patient’s attendees will be counselled about the anaesthetic procedure and received in pre-operative room on the morning of surgery after confirming NPO status, recording of vitals parameters and IV line will be established and isolyte-P will be started using Holiday-Segar’s formula. Nebulization will be done by standard hospital portable nebuliser 15 minutes before induction.The baseline parameter like non-invasive blood pressure (NIBP) , electrocardiogram (ECG) , pulse rate , pulse oximetry (Spo2) , will be recorded before and after nebulization.

Patient will be shifted to the operating room theatre, all vital ASA standard monitors will be attached such as heart rate, non-invasive blood pressure, electrocardiogram, oxygen saturation and respiratory rate will be recorded. Standard method of anaesthesia will be used while inducing the patient. Premedication will be with midazolam 0.05 mg/kg, glycopyrrolate 0.04 mg/kg , induction will be with fentanyl 1mcg, propofol 2-3mg/kg and atracurium 0.5 mg/kg. Airway will be secured with an appropriate- sized airway device once the jaw is sufficiently relaxed. Size of endotracheal tube will be according to age and weight of the patient. Maintainence of anaesthesia is with O2+N2O (50:50%) and titrated sevofluorane with pressure-controlled ventilation,0.12 mg/kg atracurium at fixed intervals and maintainence of Etco2 between 35-45 mmhg. Neuromuscular blockade will be reversed with standard doses of neostigmine 0.05mg/kg and glycopyrrolate 0.01 mg/kg. After extubation , in the post anaesthesia care unit , FPS-R scale revised scoring will be recorded postoperatively. Emergence agitation will be assessed by (PAED) Pediatric Anaesthesia Emergence Delirium score and sedation will be assessed by using Modified Ramsay Sedation score. Time for oral intake will be noted . Patient will be receiving i.v. Paracetamol 10 mg/kg as rescue analgesia if requested and the total consumption of postoperative rescue analgesia will be recorded. Inj Dexamethasone 0.1 mg/kg will be used as second rescue analgesic. 

 

 
Close